top of page

Neurotrauma Biomarkers Evident after Blast Exposure without TBI Diagnosis

Service members and law enforcement personnel are routinely exposed to blast overpressure, a harmful displacement of air from explosives or weapons, during training exercises or combat. While blast exposure is associated with increased risk of brain disease or psychological disorder diagnosis later in life, personnel report symptoms that are similar traumatic brain injury (TBI) or concussion. Memory problems, headaches, and tinnitus (ringing of the ears) are common, but do not always meet the threshold for clinical diagnosis at the time of reporting.

Application of blood-based biomarker measurements has become increasingly useful to define effects of blast overpressure. GFAP, UCH-L1, tau, amyloid beta-40 and amyloid beta-42 have key roles as in brain injury and disease. In a recent study, levels of these proteins were measured within blood from study participants who were considered healthy and did not have a diagnosed TBI. Each of these biomarkers was increased among study participants with blast exposure. Moreover, tau and amyloid beta levels were higher among those who reported memory problems and tinnitus compared to those who did not. Measurement of blood-derived biomarkers with symptom assessment may become useful for monitoring effects of blast exposure.

This work was originally reported in the JAMA Network Open, Neurology

“Neurotrauma Biomarker Levels and Adverse Symptoms Among Military and Law Enforcement Personnel Exposed to Occupational Overpressure”

Without Diagnosed Traumatic Brain Injury


Angela M. Boutté*, PhD; Bharani Thangavelu, PhD; Jeffrey Nemes, MS; Christina R. LaValle, MS; Mike Egnoto, PhD; Walter Carr, PhD; Gary H. Kamimori, PhD

To learn how our expertise in brain biomarkers can augment your research needs.

Visit Aries Biotech at

58 views0 comments

Recent Posts

See All

Are you interested in #biomarkers and #therapeutics for #neurologicaldisease and #brainhealth? Aries Biotech want to hear from you! Your perspective holds immense value for us and we recognize the vit

Aries Biotech extends gratitude to CSIRO, Australia's national science agency, for inviting Dr. Angela Boutte, the founder of Aries Biotech, to discuss health initiatives. At Aries Biotech, we believ

Revolutionizing Neuroscience and Neurotrauma: Aries Biotech Announces New Services Available to KOLs and Investors Aries Biotechnologies is thrilled to introduce

bottom of page